Injectable products that claim to lighten complexions, correct uneven skin tone, and clear up blemishes are potentially unsafe and ineffective, and might contain unknown harmful ingredients or contaminants, the FDA warns.
A surgical mesh company claims the FDA improperly called one of its products’ safety into question, Medical Design & Outsourcing reports.
The FDA wants to ban tanning beds and sunlamp use for teens and children.
Some of the products targeted during Operation Pangea VIII include illegal dermal fillers such as “Interfall Hydrogel polyacrylamide dermal filler,” “Dermafil Hyaluronic acid dermal filler” and “Teosyal Hyaluronic acid dermal filler.”
Read MoreThe FDA granted marketing clearance for LIPOFINA, YOLO’s newest body contouring laser system.
Read MoreIn a much anticipated approval, the FDA has given its nod to Kythera’s Kybella to treat double chins.
Read MoreFake Botox was found in the United States and may have been sold to doctors’ offices and medical clinics nationwide, The FDA warns. Are your patients at risk?
Read MoreThe U.S Food and Drug Administration and US plastic surgeons are taking active measures to determine the nature and or scope of any possible association between ALCL and breast implants.
Read MoreAn FDA advisory panel voted unanimously to approve Kythera’s ATX-101 for the reduction of moderate-to-severe submental fat in adults.
Read MoreLearn about the steps that dermatologist Brett Coldiron, MD, FAAD, and the AAD are taking to help save the specialty.
Read MoreThe FD gave its nod to Allergan’s NATRELLE INSPIRA™ round gel-filled smooth breast implants for women undergoing breast reconstruction, augmentation, or revision surgery.
Read MoreCovidien’s VenaSeal Closure system is the first device to use adhesive to cut off blood supply.
Read MoreThe FDA has green lighted a phase III clinical study of ALPHAEON’S EVOSYAL™ for the treatment of glabellar lines.
Read MoreNovartis’ Cosentyx is the first approved human monoclonal antibody that selectively binds to interleukin IL-17A.
Read MoreNovartis’ Cosentyx is the first approved human monoclonal antibody that selectively binds to interleukin IL-17A.
Read MoreAntria Inc announced that the FDA has approved a Phase 2 study of autologous adipose derived stem cells in plastic surgery. The future is now. #regenerativemedicine
Read MoreAntria Inc announced that the FDA has approved a Phase 2 study of autologous adipose derived stem cells in plastic surgery. The future is now. #regenerativemedicine
Read More
Get the scoop on scar-reducing skin care, beauty oil, IDEAL breast implants, and postsurgery bras in PSP’s January 2015 Hot Stuff.
Read More